A Fatal Complication of Liver Transplant: Posttransplant Lymphoproliferative Disease

被引：0

作者：

Hizarcioglu-Gulsen, Hayriye ^{[1
]}

Gumus, Ersin ^{[1
]}

Demir, Hulya ^{[1
]}

Saltik-Temizel, Inci N. ^{[1
]}

Varan, Ali ^{[2
]}

Dincer, Hilmi Anil ^{[3
]}

Dogrul, Ahmet Bulent ^{[3
]}

Ozen, Hasan ^{[1
]}

机构：

[1] Hacettepe Univ, Fac Med, Dept Pediat Gastroenterol Hepatol & Nutr, TR-06100 Ankara, Turkey

[2] Hacettepe Univ, Fac Med, Dept Pediat Oncol, Ankara, Turkey

[3] Hacettepe Univ, Fac Med, Dept Gen Surg, Ankara, Turkey

来源：

EXPERIMENTAL AND CLINICAL TRANSPLANTATION | 2022年 / 20卷 / 05期

关键词：

Cytomegalovirus; Epstein-Barr virus; Lymphoma; Tacrolimus;

D O I：

10.6002/ect.PediatricSymp2022.O33

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

Immunosuppressive therapy is a double-edged sword and causes a risk for some complications, such as opportunistic infections and posttransplant lymphoproliferative disease. The most likely risk factors for posttransplant lymphoproliferative disease are Epstein-Barr virus serology mismatch, prolonged and high viral load for Epstein-Barr virus, higher doses of immunosuppressive therapy, and cytomegalovirus infection. Transplant recipients who are seropositive for Epstein-Barr virus show a lower risk for posttransplant lymphoproliferative disease than seronegative recipients. Here, we present a 3.5-year-old boy who was seropositive for Epstein-Barr virus and developed posttransplant lymphoproliferative disease 18 months after liver transplant with a previous history of cytomegalovirusrelated pneumatosis intestinalis.

引用

页码：102 / 104

页数：3

共 50 条

[1] Posttransplant lymphoproliferative disease in liver transplant patients
Hartmann C.
Schuchmann M.
Zimmermann T.
Current Infectious Disease Reports, 2011, 13 (1) : 53 - 59
[2] A Mimic of Posttransplant Lymphoproliferative Disease Following Liver Transplant
Kitchens, William H.
Jaye, David L.
Wedd, Joel P.
Magliocca, Joseph F.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2020, 18 (06) : 741 - 743
[3] Posttransplant Lymphoproliferative Disease in Pediatric Liver Transplant Recipients
Sevmis, S.
Pehlivan, S.
Shabazov, R.
Karakayali, H.
Ozcay, F.
Haberal, M.
TRANSPLANTATION PROCEEDINGS, 2009, 41 (07) : 2881 - 2883
[4] Early posttransplant lymphoproliferative disease in pediatric liver transplant recipients
Roque, J
Rios, G
Humeres, R
Volpi, C
Herrera, JM
Schultz, M
Rios, H
Rius, M
Salgado, C
Hepp, J
TRANSPLANTATION PROCEEDINGS, 2006, 38 (03) : 930 - 931
[5] The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients
Younes, BS
McDiarmid, SV
Martin, MG
Vargas, JH
Goss, JA
Busuttil, RW
Ament, ME
TRANSPLANTATION, 2000, 70 (01) : 94 - 99
[6] Primary ocular posttransplant lymphoproliferative disease in pediatric liver transplant patients
O'Connor, JA
Lin, JC
Cordle, RA
Lloyd, WC
Lillis, PK
O'Hara, M
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2001, 32 (01): : 89 - 91
[7] Posttransplant lymphoproliferative disorder in liver transplant recipients
Liu, Y.
Sun, L. Y.
Zhu, Z. J.
Wei, L.
Qu, W.
Zeng, Z. G.
TRANSPLANTATION, 2018, 102 : 328 - 329
[8] Posttransplant Lymphoproliferative Disorder in Liver Transplant Recipients
Liu, Ying
Sun, Li-Ying
Zhu, Zhi-Jun
Wei, Lin
Qu, Wei
Zeng, Zhi-Gui
TRANSPLANTATION, 2018, 102 : S605 - S605
[9] Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients
Molmenti, EP
Nagata, D
Roden, J
Squires, R
Molmenti, H
Casey, D
Fasola, C
Lopez, MJ
Winick, N
McPhail, W
D'Amico, L
Goldstein, R
Levy, M
Fasola, C
Andersen, J
Klintmalm, G
TRANSPLANTATION PROCEEDINGS, 2001, 33 (1-2) : 1727 - 1727
[10] Posttransplant Lymphoproliferative Disorder After Liver and Kidney Transplant
Ozkan, Eylem Akar
Ozdemir, B. Handan
Deniz, E. Ebru
Tunca, M. Zeyneb
Haberal, Mehmet
EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2014, 12 : 142 - 148

← 1 2 3 4 5 →